<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02827448</url>
  </required_header>
  <id_info>
    <org_study_id>BRI - 015-179</org_study_id>
    <nct_id>NCT02827448</nct_id>
  </id_info>
  <brief_title>Effectiveness of NephroCheckTM Test to Predict Acute Kidney Injury Following Advanced Cardiac Replacement Therapies</brief_title>
  <official_title>Urinary Cell Cycle Arrest Biomarkers as Early Predictors of Acute Kidney Injury Following Advanced Cardiac Replacement Therapies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baylor Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baylor Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test how well the NephroCheckTM Test, a noninvasive
      laboratory test performed on urine, predicts loss of kidney function in patients that have
      had a heart transplant or a Left Ventricular Assist Device (LVAD) or Total Artificial Heart
      (TAH) implanted.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Current strategies for AKI detection rely primarily on elevations in serum creatinine in
      conjunction with diminished urine output. Unfortunately, deviations in these crude parameters
      of renal function are largely insensitive and late manifestations of AKI, where acute tubular
      necrosis has likely already transpired and therefore well beyond the phase where preventive
      measures may be instituted. Early phase biomarkers, insulin-like growth factor-binding
      protein 7 (&quot;IGFBP7&quot;) and tissue inhibitor of metalloproteinases-2 (&quot;TIMP-2&quot;) are critical
      mediators of G1 cell cycle arrest of renal tubular cells during the early phase of cellular
      injury, providing a potential therapeutic window to prevent permanent damage. To date, no
      study has evaluated the efficacy of these early phase renal biomarkers for detecting AKI in
      advanced heart failure patients undergoing cardiac replacement therapies.

      Therefore, the aim of this prospective observational study will be to evaluate the
      effectiveness of the NephroCheckTM to predict AKI in patients undergoing transplant, LVAD
      implant, or TAH implant.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>[TIMP-2]*[IGFBP7] measurement using NephroCheck following LVAD or TAH implantation</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Occurrence of AKI following LVAD or TAH implantation</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>[TIMP-2]*[IGFBP7] measurement using NephroCheck following cardiac transplantation</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Acute Kidney Injury</condition>
  <condition>Heart Failure</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients that have had a heart transplant or LVAD implant.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who will receive LVAD or heart transplantation

        Exclusion Criteria:

          -  Patients who are unable to give consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susan Joseph, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baylor University Medical Center at Dallas</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Horacio Martinez, BS, CCRC</last_name>
    <phone>214-820-0338</phone>
    <email>Horacio.Martinez@BSWHealth.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carmen Bonilla, BSN, RN</last_name>
    <phone>214-818-2588</phone>
    <email>Carmen.Bonilla@BSWHealth.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Baylor Research Institute</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Horacio Martinez, BS, CCRC</last_name>
      <phone>214-820-0338</phone>
      <email>Horacio.Martinez@BSWHealth.org</email>
    </contact>
    <contact_backup>
      <last_name>Carmen Bonilla, BSN, RN</last_name>
      <phone>214-818-2588</phone>
      <email>Carmen.Bonilla@BSWHealth.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Hobson CE, Yavas S, Segal MS, Schold JD, Tribble CG, Layon AJ, Bihorac A. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation. 2009 May 12;119(18):2444-53. doi: 10.1161/CIRCULATIONAHA.108.800011. Epub 2009 Apr 27.</citation>
    <PMID>19398670</PMID>
  </reference>
  <reference>
    <citation>Boyle JM, Moualla S, Arrigain S, Worley S, Bakri MH, Starling RC, Heyka R, Thakar CV. Risks and outcomes of acute kidney injury requiring dialysis after cardiac transplantation. Am J Kidney Dis. 2006 Nov;48(5):787-96.</citation>
    <PMID>17059998</PMID>
  </reference>
  <reference>
    <citation>Odim J, Wheat J, Laks H, Kobashigawa J, Gjertson D, Osugi A, Mukherjee K, Saleh S. Peri-operative renal function and outcome after orthotopic heart transplantation. J Heart Lung Transplant. 2006 Feb;25(2):162-6.</citation>
    <PMID>16446215</PMID>
  </reference>
  <reference>
    <citation>Topkara VK, Dang NC, Barili F, Cheema FH, Martens TP, George I, Bardakci H, Oz MC, Naka Y. Predictors and outcomes of continuous veno-venous hemodialysis use after implantation of a left ventricular assist device. J Heart Lung Transplant. 2006 Apr;25(4):404-8. Epub 2006 Feb 28.</citation>
    <PMID>16563969</PMID>
  </reference>
  <reference>
    <citation>Borgi J, Tsiouris A, Hodari A, Cogan CM, Paone G, Morgan JA. Significance of postoperative acute renal failure after continuous-flow left ventricular assist device implantation. Ann Thorac Surg. 2013 Jan;95(1):163-9. doi: 10.1016/j.athoracsur.2012.08.076. Epub 2012 Oct 25.</citation>
    <PMID>23103012</PMID>
  </reference>
  <reference>
    <citation>Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M, Bihorac A, Birkhahn R, Cely CM, Chawla LS, Davison DL, Feldkamp T, Forni LG, Gong MN, Gunnerson KJ, Haase M, Hackett J, Honore PM, Hoste EA, Joannes-Boyau O, Joannidis M, Kim P, Koyner JL, Laskowitz DT, Lissauer ME, Marx G, McCullough PA, Mullaney S, Ostermann M, Rimmelé T, Shapiro NI, Shaw AD, Shi J, Sprague AM, Vincent JL, Vinsonneau C, Wagner L, Walker MG, Wilkerson RG, Zacharowski K, Kellum JA. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013 Feb 6;17(1):R25. doi: 10.1186/cc12503.</citation>
    <PMID>23388612</PMID>
  </reference>
  <reference>
    <citation>Bihorac A, Chawla LS, Shaw AD, Al-Khafaji A, Davison DL, Demuth GE, Fitzgerald R, Gong MN, Graham DD, Gunnerson K, Heung M, Jortani S, Kleerup E, Koyner JL, Krell K, Letourneau J, Lissauer M, Miner J, Nguyen HB, Ortega LM, Self WH, Sellman R, Shi J, Straseski J, Szalados JE, Wilber ST, Walker MG, Wilson J, Wunderink R, Zimmerman J, Kellum JA. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med. 2014 Apr 15;189(8):932-9. doi: 10.1164/rccm.201401-0077OC.</citation>
    <PMID>24559465</PMID>
  </reference>
  <reference>
    <citation>Meersch M, Schmidt C, Van Aken H, Martens S, Rossaint J, Singbartl K, Görlich D, Kellum JA, Zarbock A. Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery. PLoS One. 2014 Mar 27;9(3):e93460. doi: 10.1371/journal.pone.0093460. eCollection 2014.</citation>
    <PMID>24675717</PMID>
  </reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 24, 2015</study_first_submitted>
  <study_first_submitted_qc>July 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 11, 2016</study_first_posted>
  <last_update_submitted>December 5, 2017</last_update_submitted>
  <last_update_submitted_qc>December 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Left Ventricular Assist Device</keyword>
  <keyword>Heart Transplantation</keyword>
  <keyword>Perioperative</keyword>
  <keyword>Acute Kidney Injury</keyword>
  <keyword>Renal</keyword>
  <keyword>Kidney</keyword>
  <keyword>Total Artificial Heart</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

